Home | Welcome to Contract Pharma   
Last Updated Friday, October 31 2014
Print

Search Results for 'Financial Report: Alexion'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published October 28, 2014
Merck 3Q Revenues: $10.6 billion  (-4%) 3Q Earnings: $842 million (-27%) YTD Revenues: $31.8 billion (-3%) YTD Earnings: $4.6 billion (+24%) Comments: Pharmaceutical sales were $9.1 billion in the quarter, down 4%. JANUVIA/JANUMET sales wer… Read More »
Published October 23, 2014
Soliris sales up 39% in the quarter Read More »
Published October 14, 2014
Pharmaceutical sales up 18% in the quarter, new products drive growth Read More »
Published April 24, 2014
Solaris revenue up 67% in the quarter Read More »
By Gil Roth
Published January 30, 2014
Soliris sales continue to climb Read More »
Published February 14, 2013
Solaris sales climb 41% in the quarter Read More »
Published July 21, 2011
Soliris sales jump 48% to $185.7 million. Read More »
By Michael Martorelli
Published November 6, 2009
Feel Better Now? Ending one year, approaching the next By Michael A. Martorelli It’s always interesting to write a column about an event that is still in my future, but will have already happened by the time you read my words. Th… Read More »
Solaris revenue up 67% in the quarter Read More »
By Mr. Deepak Bahri, President
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On